Evercore ISI lowers Accenture stock price target to $300 on cross-currents

Accenture (ACN) has experienced multiple analyst price target reductions, including Evercore ISI lowering its target to $300 from $330, ahead of its Q4 earnings report, with the stock down 32.1% year-to-date and near its 52-week low. While Evercore anticipates Q4 results to be in-line to slightly above consensus, investors are closely watching bookings performance, AI contributions, U.S. federal spending headwinds, and the significant potential impact of a proposed $100,000 H-1B visa fee, which has already pressured shares. The company recently acquired Orlade Group to enhance its capital projects capabilities.

Analysis

Accenture (ACN) is approaching its fiscal Q4 earnings report under significant market pressure, as evidenced by a 32.1% year-to-date stock decline and trading activity near its 52-week low. Despite this underperformance, multiple analysts, including Evercore, Wolfe, and Stifel, maintain 'Outperform' or 'Buy' ratings, albeit with recently reduced price targets—Evercore, for instance, lowered its target to $300 from $330. This dichotomy suggests analysts perceive the stock as undervalued at its current P/E ratio of 18.67, but acknowledge near-term headwinds. Evercore anticipates Q4 results to be in-line or slightly above consensus estimates of $17.4 billion in revenue. However, investor focus will be on several key risk factors: a ~2 percentage point growth headwind from reduced U.S. Federal government spending, challenging year-over-year comparisons for bookings, and the potential impact of a proposed $100,000 fee for H-1B visas, which could disrupt its talent acquisition model. While the recent acquisition of Orlade Group modestly strengthens its Industry X practice, the market's primary concerns are centered on future growth guidance and management's strategy to navigate these macroeconomic and regulatory challenges, particularly the contribution of AI to offset slowing growth.

Key Decisions for Investors

• Investors should closely scrutinize the upcoming Q4 earnings call for management's specific commentary on bookings performance, the quantifiable impact of AI on revenue, and any mitigation strategies for the U.S. federal spending and H-1B visa headwinds.
• While the stock's valuation appears attractive near its 52-week low, the multiple downward price target revisions and significant regulatory risk warrant caution; consider holding existing positions pending clarity from the earnings report rather than initiating new ones.
• Evaluate the company's fiscal Q1 and full-year 2026 guidance carefully, as any deviation from the consensus revenue expectations of $18.5 billion and $73.2 billion, respectively, will be a primary catalyst for the stock's direction.